CN102250119B - 一种由萘夫西林酸制备萘夫西林钠一水合物的方法 - Google Patents
一种由萘夫西林酸制备萘夫西林钠一水合物的方法 Download PDFInfo
- Publication number
- CN102250119B CN102250119B CN2011101378682A CN201110137868A CN102250119B CN 102250119 B CN102250119 B CN 102250119B CN 2011101378682 A CN2011101378682 A CN 2011101378682A CN 201110137868 A CN201110137868 A CN 201110137868A CN 102250119 B CN102250119 B CN 102250119B
- Authority
- CN
- China
- Prior art keywords
- nafcillin
- sodium
- organic solvent
- hydrate
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- OCXSDHJRMYFTMA-KMFBOIRUSA-M nafcillin sodium monohydrate Chemical compound O.[Na+].C1=CC=CC2=C(C(=O)N[C@@H]3C(N4[C@H](C(C)(C)S[C@@H]43)C([O-])=O)=O)C(OCC)=CC=C21 OCXSDHJRMYFTMA-KMFBOIRUSA-M 0.000 title claims abstract description 30
- 239000002253 acid Substances 0.000 title claims abstract description 27
- 229960000515 nafcillin Drugs 0.000 title claims abstract description 27
- GPXLMGHLHQJAGZ-JTDSTZFVSA-N nafcillin Chemical compound C1=CC=CC2=C(C(=O)N[C@@H]3C(N4[C@H](C(C)(C)S[C@@H]43)C(O)=O)=O)C(OCC)=CC=C21 GPXLMGHLHQJAGZ-JTDSTZFVSA-N 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title claims abstract description 20
- 229960004387 nafcillin sodium monohydrate Drugs 0.000 title abstract 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000003756 stirring Methods 0.000 claims abstract description 20
- 239000003960 organic solvent Substances 0.000 claims abstract description 19
- 239000013078 crystal Substances 0.000 claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 238000001816 cooling Methods 0.000 claims abstract description 8
- 238000005406 washing Methods 0.000 claims abstract description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 30
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 14
- 239000012065 filter cake Substances 0.000 claims description 7
- 239000000178 monomer Substances 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 7
- 229920002554 vinyl polymer Polymers 0.000 claims description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- 239000012046 mixed solvent Substances 0.000 claims description 5
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical compound CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 229940040526 anhydrous sodium acetate Drugs 0.000 claims description 4
- 238000009413 insulation Methods 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 claims description 3
- 235000021050 feed intake Nutrition 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- 229940087562 sodium acetate trihydrate Drugs 0.000 claims description 3
- 238000010009 beating Methods 0.000 claims description 2
- 239000012452 mother liquor Substances 0.000 claims description 2
- 229940083542 sodium Drugs 0.000 claims description 2
- 239000002904 solvent Substances 0.000 abstract description 9
- 238000001035 drying Methods 0.000 abstract description 6
- 150000007530 organic bases Chemical class 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- 239000003513 alkali Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 239000011229 interlayer Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229960001775 nafcillin sodium Drugs 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 239000008399 tap water Substances 0.000 description 5
- 235000020679 tap water Nutrition 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010189 synthetic method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000003952 β-lactams Chemical class 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010071699 Infectious pleural effusion Diseases 0.000 description 1
- 206010024652 Liver abscess Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- -1 carbon chain ketone Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Substances [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101378682A CN102250119B (zh) | 2011-05-26 | 2011-05-26 | 一种由萘夫西林酸制备萘夫西林钠一水合物的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101378682A CN102250119B (zh) | 2011-05-26 | 2011-05-26 | 一种由萘夫西林酸制备萘夫西林钠一水合物的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102250119A CN102250119A (zh) | 2011-11-23 |
CN102250119B true CN102250119B (zh) | 2013-11-27 |
Family
ID=44977727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101378682A Active CN102250119B (zh) | 2011-05-26 | 2011-05-26 | 一种由萘夫西林酸制备萘夫西林钠一水合物的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102250119B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106800565A (zh) * | 2016-12-08 | 2017-06-06 | 桂林南药股份有限公司 | 一种萘夫西林钠晶型及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101456869A (zh) * | 2008-12-30 | 2009-06-17 | 华北制药集团山西博康药业有限公司 | 萘夫西林钠的合成方法 |
CN101659670A (zh) * | 2009-10-10 | 2010-03-03 | 北京紫萌同达科技有限公司 | 一种由萘夫西林酸一步法合成萘夫西林钠一水合物的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2951839A (en) * | 1959-07-15 | 1960-09-06 | Doyle Frank Peter | Synthetic penicillins |
US3506645A (en) * | 1968-05-03 | 1970-04-14 | American Home Prod | Monohydrate of sodium salt of 6-(2-ethoxy - 1-naphthamido)penicillanic acid and method of preparation |
-
2011
- 2011-05-26 CN CN2011101378682A patent/CN102250119B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101456869A (zh) * | 2008-12-30 | 2009-06-17 | 华北制药集团山西博康药业有限公司 | 萘夫西林钠的合成方法 |
CN101659670A (zh) * | 2009-10-10 | 2010-03-03 | 北京紫萌同达科技有限公司 | 一种由萘夫西林酸一步法合成萘夫西林钠一水合物的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102250119A (zh) | 2011-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104327100B (zh) | 高纯度氟氧头孢钠制备工艺 | |
CN101319246A (zh) | 头孢克肟的制备方法 | |
CN104693129B (zh) | 一种无孪晶llm‑105炸药的结晶方法 | |
CN101486719A (zh) | 头孢噻肟酸转钠盐结晶方法 | |
CN101570543A (zh) | 一种美洛西林钠溶媒结晶制备方法 | |
CN102311450B (zh) | 阿洛西林钠的制备方法 | |
CN102250119B (zh) | 一种由萘夫西林酸制备萘夫西林钠一水合物的方法 | |
CN100569779C (zh) | 葡醛内酯的生产工艺 | |
CN102050737A (zh) | 一种截短侧耳素的提取纯化方法 | |
CN104447800A (zh) | 一种头孢西丁酸的合成技术 | |
CN112552167B (zh) | 葡萄糖酸钙的制备方法 | |
CN102070523A (zh) | 制备3-羟基喹哪啶-4-羧酸的新方法 | |
CN106987608B (zh) | 一种葡萄糖酸钙的动态结晶法 | |
CN101307060A (zh) | 左氧氟沙星半水化合物的制备工艺 | |
CN100427489C (zh) | 阿洛西林钠制备方法 | |
CN112897599A (zh) | 一种硫酸镍、钴、锰的结晶方法 | |
CN1931724A (zh) | 高纯氧化钇铕的制备方法 | |
CN101456869B (zh) | 萘夫西林钠的合成方法 | |
CN103012437A (zh) | 抗菌药物头孢西丁酸的制备方法 | |
CN104276944A (zh) | 2,4-二氯苯氧乙酸连续反应结晶粒度控制方法 | |
CN106749332B (zh) | 氨苄西林钠晶体的生产工艺 | |
CN102250120A (zh) | 一种萘夫西林钠一水合物的制备方法 | |
CN103923099A (zh) | 一种莫能菌素晶体或其钠盐的制备方法 | |
CN105254650A (zh) | 抗菌药物头孢西丁酸的合成方法 | |
CN103044361B (zh) | 一种(2r,3s)-环氧化氨基苯丁烷的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 030021 No. 1, Chemical Road, Jinyuan District, Shanxi, Taiyuan Applicant after: North Pharmaceutical Group Shanxi Bokang Pharmaceutical Co.,Ltd. Address before: 030021 No. 1, Chemical Road, Jinyuan District, Shanxi, Taiyuan Applicant before: North Pharmaceutical Group Shanxi Bokang Pharmaceutical Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SHANXI BOKANG PHARMACEUTICAL CO., LTD. OF NCPC TO: LONGCH GROUP GUARDDIAN PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191119 Address after: 100176 No.1, dize North Street, Beijing Economic and Technological Development Zone, Daxing District, Beijing Patentee after: Beijing shengkejia Electronic Co., Ltd Address before: 030021 No. 1, Chemical Road, Jinyuan District, Shanxi, Taiyuan Patentee before: Langzhi Group Bokang Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201119 Address after: No.8, Industrial Avenue, furniture base, Longling Industrial Park, Nankang District, Ganzhou City, Jiangxi Province Patentee after: LONCH GROUP JIANGXI PHARMACEUTICAL Co.,Ltd. Address before: 100176 No.1, dize North Street, Beijing Economic and Technological Development Zone, Daxing District, Beijing Patentee before: Beijing shengkejia Electronic Co.,Ltd. |